Prostatic Urethral Lift: A Unique Minimally Invasive Surgical Treatment of Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Urologic Clinics of North America

Volumn 43, Issue 3, 2016, Pages 357-369

  Roehrborn, Claus G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Benign prostatic hyperplasia; Lower urinary tract symptoms; Minimally invasive therapy; Prostatic urethral lift; Sexual function; Surgical therapy

Indexed keywords

ANESTHESIA INDUCTION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; IMPLANT DELIVERY DEVICE; INTERNATIONAL PROSTATE SYMPTOM SCORE; LASER SURGERY; LASER VAPORIZATION; LOCAL ANESTHESIA; LOWER URINARY TRACT SYMPTOM; MALE; MINIMALLY INVASIVE SURGERY; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT POSITIONING; PATIENT SAFETY; PATIENT SELECTION; PENIS ERECTION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE IMPLANT; PROSTATIC URETHRAL LIFT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION CARE; REOPERATION; REVIEW; RISK BENEFIT ANALYSIS; SEXUAL FUNCTION; SURGICAL APPROACH; SURGICAL RISK; TRANSURETHRAL RESECTION; TREATMENT PLANNING; TREATMENT RESPONSE; UROLOGICAL PROSTHESIS; COMPLICATION; LOWER URINARY TRACT SYMPTOMS; MALE GENITAL SYSTEM SURGERY; MICTURITION; PATHOPHYSIOLOGY; PROCEDURES; PROSTATIC HYPERPLASIA; URETHRA;

HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MINIMALLY INVASIVE SURGICAL PROCEDURES; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; URETHRA; URINATION; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 84991688477     PISSN: 00940143     EISSN: 1558318X     Source Type: Journal    
DOI: 10.1016/j.ucl.2016.04.008     Document Type: Review

References (30)

1. 1 Roehrborn, C., McConnell, J., Barry, M., et al. American Urological Association guideline: management of benign prostatic hyperplasia (BPH). 2003, American Urological Association Education and Research Inc, Linthicum (MD).
2. 2 Verhamme, K., Dieleman, J., Bleumink, G., et al. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the triumph project. Eur Urol 44 (2003), 539–545.
3. 3 Reich, O., Gratzke, C., Bachmann, A., et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180 (2008), 246–249.
4. 4 Bachmann, A., Tubaro, A., Barber, N., et al. A European multicenter randomized noninferiority trial comparing 180 W Greenlight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign obstruction: 12-month results of the GOLIATH study. J Urol 193 (2015), 1–9.
5. 5 Miano, R., De Nunzio, C., Asimakopoulos, A.D., et al. Treatment options for benign prostatic hyperplasia in older men. Med Sci Monit 14:7 (2008), RA94–102.
6. 6 Summary of Safety and Effectiveness, Prostalund CoreTherm Microwave Therapy System, PreMarket Approval (PMA) Number P010055.
7. 7 Norby, B., Nielsen, H.V., Frimodt-moller, P.C., Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 90 (2002), 853–862.
8. 8 Ahmed, M., Bell, T., Lawrence, W.T., et al. Transurethral microwave thermotherapy (Prostatron@version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol 79 (1997), 181–185.
9. 9 Roehrborn, C., Rukstalis, D., Barkin, J., et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 22:3 (2015), 7772–7782.
10. 10 Yu, X., Elliott, S.P., Wilt, T.J., et al. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol, 180, 2008, 241.
11. 11 Medicare data calculated from the Medicare Physician/Supplier Procedure Summary Master File, 2004-2007.
12. 12 Roehrborn, C., Gange, S., Shore, N., et al. Multi-center randomized controlled blinded study of the prostatic urethral lift for the treatment of LUTS associated with prostate enlargement due to BPH: the LIFT study. J Urol 190:6 (2013), 2161–2167.
13. 13 Sonksen, J., Barber, N.H., Speakman, M., et al. Prospective, randomized, multinational study of prostatic urethral life versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 68:4 (2015), 643–652.
14. 14 Woo, H.H., Chin, P.T., McNicholas, T.A., et al. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int, 108, 2011, 82.
15. 15 Chin, P.T., Boiton, D.M., Jack, G., et al. Prostatic urethral lift: two-year results after treatment for lower urinary symptoms secondary to benign prostatic hyperplasia. Urology, 79, 2012, 5.
16. 16 Shore, N., Freedman, S., Gange, S., et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol 21 (2014), 7094–7101.
17. 17 McNicholas, T., Woo, H., Chin, P., et al. Minimally invasive prostatic urethral lift: surgical technique and multinational study. Eur Urol 64 (2013), 292–299.
18. 18 Mogensen, K., Jacobsen, J., The load on family and primary healthcare in the first six weeks after transurethral resection of the prostate. Scand J Urol Nephrol 42 (2008), 132–136.
19. 19 Cantwell, A.L., Bogache, W.K., Richardson, S.F., et al. Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int 113:4 (2014), 615–622.
20. 20 Wasson, J., Reda, D., Bruskewitz, R., et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 332 (1995), 75–79.
21. 21 Glass, J., Bdesha, A., Witherow, R., Microwave thermotherapy: a long-term follow-up of 67 patients from a single centre. Br J Urol 81 (1998), 377–382.
22. 22 Lau, K., Li, M., Foo, K., Long-term follow-up of transurethral microwave thermotherapy. Urology 52 (1998), 829–833.
23. 23 Hill, B., Belville, W., Bruskewitz, R., et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 171 (2004), 2336–2340.
24. 24 McVary, K., Gange, S., Shore, N., et al. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med 11 (2014), 279–287.
25. 25 Gravas, S., Bachmann, A., Reich, O., et al. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int 107 (2011), 1030–1043.
26. 26 Spailviero, M., Strom, K.H., Gu, X., et al. Does greenlight HPS laser photoselective vaporization prostatectomy affect sexual function?. J Endourol 24 (2010), 2051–2057.
27. 27 Frieben, R.W., Lin, H.C., Hinh, P.P., et al. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function; a systematic review. Asian J Androl 12 (2010), 500–508.
28. 28 Gupta, N., Sivaramakrisna, Kumar, R., et al. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia >40 g. BJU Int 97 (2006), 85–89.
29. 29 Montorsi, F., Moncada, I., Safety and tolerability of treatment for BPH. Eur Urol 5 (2006), 989–1024.
30. 30 Roehrborn, C., Gange, S., Shore, N., et al. Durability of the prostatic urethral lift: 2-year results of the L.I.F.T. study. Urol Pract 2 (2015), 1–7.